PHÂN TÍCH TÌNH HÌNH SỬ DỤNG THUỐC VÀ TẦN SUẤT CHỈ ĐỊNH CẬN LÂM SÀNG TRÊN BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TUÝP 2 ĐIỀU TRỊ NGOẠI TRÚ TẠI BỆNH VIỆN ĐA KHOA GIA LÂM

Abstract

Objective: To analyze the current status of medication use and the frequency of paraclinical test ordering in the treatment of type 2 diabetes mellitus at Gia Lam Hospital from July 2024 to July 2025. Subjects and Methods: A non-interventional retrospective study using outpatient medical records. The study population included type 2 diabetes patients undergoing monthly follow-up visits from 01/07/2024 to 31/07/2025. A systematic sampling method was applied with a calculated sample size of 196. Results: The mean age of patients was 67 ± 10 years. Most patients had stable baseline laboratory results as they had been receiving treatment prior to the study period. Regarding the frequency of paraclinical testing, blood glucose and HbA1c measurements were performed on average 3–4 times per year, in accordance with the recommendations of the Ministry of Health. In diabetes management, insulin-containing regimens accounted for 18.4%, of which insulin monotherapy represented 51%. Oral-only regimens were more common (81.6%), mainly dual therapy with metformin and a sulfonylurea (57%). For the treatment of hypertension, the most frequently used regimen was ACE inhibitors or angiotensin receptor blockers combined with diuretics (35%). In lipid management, statins were the predominant drugs used (82%). Conclusion: The treatment and use of medications, as well as the monitoring of laboratory tests and paraclinical investigations at the hospital, are generally adequate and in accordance with current treatment guidelines and should be maintained. However, the diabetes drug formulary should be diversified and statin intensity optimized to enhance cardiovascular and renal protection for patients.